Clinicopathological Significance of Invasive Ductal Carcinoma with High Prevalence of CD44+/CD24-/low Tumor Cells in Breast Cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Epithelial tumor cells with a CD44+/CD24-/low immunoprofile may have the ability to cause breast cancer. We studied these cells and their clinicopathological significance. Methods : The clinicopathologic findings of 100 invasive ductal carcinoma (IDC) cases and 45 ductal carcinoma in situ (DCIS) cases were reviewed. CD44+/CD24-/low tumor cells were identified by immunohistochemistry, and their clinicopathological implications in IDC and DCIS were analyzed. Results : IDC with a high prevalence of CD44+/CD24-/low tumor cells was significantly associated with larger mass, higher grade, estrogen receptor (ER) negativity, and tumor cells with a higher frequency of metastasis. The proportion of CD44+/CD24-/low tumor cells in IDC, and its DCIS components was not significantly different, whereas the proportion of CD44+/CD24-/low tumor cells was higher in DCIS than in the DCIS component of IDC (p < 0.001). Conclusions : IDC with a high prevalence of CD44+/CD24-/low tumor cells might correlate with aggressive features, such as ER and higher grades. Moreover, the proportion of CD44+/CD24-/low tumor cells in the DCIS components of IDC and DCIS might harbor different biology, which may lead to differences in cancer progression and early carcinogenesis.
Abstract
Background : Epithelial tumor cells with a CD44+/CD24-/low immunoprofile may have the ability to cause breast cancer. We studied these cells and their clinicopathological significance. Methods : The clinicopathologic findings of 100 invasive ductal carcinoma (IDC) cases and 45 ductal carcinoma in situ (DCIS) cases were reviewed. CD44+/CD24-/low tumor cells were identified by immunohistochemistry, and their clinicopathological implications in IDC and DCIS were analyzed. Results : IDC with a high prevalence of CD44+/CD24-/low tumor cells was significantly associated with larger mass, higher grade, estrogen receptor (ER) negativity, and tumor cells with a higher frequency of metastasis. The proportion of CD44+/CD24-/low tumor cells in IDC, and its DCIS components was not significantly different, whereas the proportion of CD44+/CD24-/low tumor cells was higher in DCIS than in the DCIS component of IDC (p < 0.001). Conclusions : IDC with a high prevalence of CD44+/CD24-/low tumor cells might correlate with aggressive features, such as ER and higher grades. Moreover, the proportion of CD44+/CD24-/low tumor cells in the DCIS components of IDC and DCIS might harbor different biology, which may lead to differences in cancer progression and early carcinogenesis.
참고문헌 (21)
- Kamangar F, "Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world", J Clin Oncol, 24, pp.2137~2150 (2006)
- Reya T, "Stem cells,cancer,and cancer stem cells", Nature, 414, pp.105~111 (2001)
- Ailles LE, "Cancer stem cells in solid tumors", Curr Opin Biotechnol, 18, pp.460~466 (2007)
- Bonnet D, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat Med, 3, pp.730~737 (1997)
- Al-Hajj M, "Prospective identification of tumorigenic breast cancer cells", Proc Natl Acad Sci U S A, 100, pp.3983~3988 (2003)
- Allred DC, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis", Mod Pathol, 11, pp.155~168 (1998)
- Jacobs TW, "Specificity of HercepTest in determining HER-2", neu status of breast cancers using the United States Food and Drug Administration-approved scoring system, 1999, pp.17, 1983~1987
- Abraham BK, "Prevalence of CD44+", CD24-, Clin Cancer Res, pp.2005, 11[DOI]
- Shipitsin M, "Molecular definition of breast tumor heterogeneity", Cancer Cell, 11, pp.259~273 (2007)
- Schindelmann S, "Expression profiling of mammary carcinoma cell lines:correlation of in vitro invasiveness with expression of CD24", Tumour Biol, 23, pp.139~145 (2002)
- Booth BW, "Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands", Breast Cancer Res, 8, pp.R49~ (2006)
- Asselin-Labat ML, "Steroid hormone receptor status of mouse mammary stem cells", J Natl Cancer Inst, 98, pp.1011~1014 (2006)
- Dontu G, "Breast cancer,stem", progenitor cells and the estrogen receptor, 2004, pp.15, 193~197
- Behbod F, "An intraductal human-inmouse transplantation model mimics the subtypes of ductal carcinoma in situ", Breast Cancer Res, 11, pp.R66~ (2009)
- Sheridan C, "CD44+", CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis, 2006, pp.8, R59~
- Wright MH, "Brca1 breast tumors contain distinct CD44+", CD24- and CD133+ cells with cancer stem cell characteristics, 2008, pp.10, R10~
- Harrison DE, "Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil", Blood, 78, pp.1237~1240 (1991)
- Zhou S, "The ABC transporter Bcrp1", ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, 2001, pp.7, 1028~1034
- Feuerhake F, "Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium", Cell Tissue Res, 299, pp.47~58 (2000)
- Peters R, "Apoptotic regulation in primitive hematopoietic precursors", Blood, 92, pp.2041~2052 (1998)
- Phillips TM, "The response of CD24(-", low), J Natl Cancer Inst, pp.2006, 98[DOI]